Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
08/2012
08/02/2012WO2012103186A2 Androgen composition for treating an opthalmic condition
08/02/2012WO2012103012A1 Methods for generating inner ear cells in vitro
08/02/2012WO2012102625A2 Therapeutic composition
08/02/2012WO2012102361A1 Aromatase activator
08/02/2012WO2012102357A1 Bicyclic compound and use thereof for medical purposes
08/02/2012WO2012102355A1 Bicyclic compound and use thereof for medical purposes
08/02/2012WO2012100459A1 Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application
08/02/2012WO2012047893A3 Use of rifazil and analogues thereof to treat ocular disorders
08/02/2012US20120197027 Quinazoline Derivatives as Angiogenesis Inhibitors
08/02/2012US20120196937 Treatment of ophthalmic disorders using urea
08/02/2012US20120196934 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form and a surfactant, and methods and uses thereof
08/02/2012US20120196925 Therapeutic and Diagnostic Molecules
08/02/2012US20120196916 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
08/02/2012US20120196914 Ketorolac tromethamine compositions for treating or preventing ocular pain
08/02/2012US20120196913 Ketorolac tromethamine compositions for treating or preventing ocular pain
08/02/2012US20120196911 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
08/02/2012US20120196902 Sulfoximines as kinase inhibitors
08/02/2012US20120196900 Pyridine non-classical cannabinoid compounds and related methods of use
08/02/2012US20120196869 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/02/2012US20120196868 Therapeutic compositions and methods
08/02/2012US20120196861 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196860 Triazine derivatives and their therapeutical applications
08/02/2012US20120196857 Modulators of Muscarinic Receptors
08/02/2012US20120196852 Inhibitors of methionine aminopeptidases and methods of treating disorders
08/02/2012US20120196844 Compounds and compositions as modulators of gpr119 activity
08/02/2012US20120196812 Pharmaceutical composition, methods for treating and uses thereof
08/02/2012US20120196808 Peptidic Vasopressin Receptor Agonists
08/02/2012US20120195985 Glycine transporter-1 inhibitors
08/02/2012US20120195972 Ophthalmic formulations and uses thereof
08/02/2012US20120195953 Fibrin sealant (FIBRINGLURAAS) consisting of a kit of lyophilized high concentrate fribinogen intentionally enriched and preserved with fibronolysis inhibitor A1AT
08/02/2012US20120195934 Polymeric gel delivery system for pharmaceuticals
08/02/2012US20120195901 Compositions and Methods for Binding Lysophosphatidic Acid
08/02/2012CA2825858A1 Phosphorus-containing group-substituted quinoline, its preparation process, medical composition containing the compound and application
08/02/2012CA2825396A1 Androgen composition for treating an opthalmic condition
08/01/2012EP2481738A1 Maleic acid salt and crystal thereof
08/01/2012EP2481416A1 Eye drops
08/01/2012EP2481399A1 Sustained drug delivery system
08/01/2012EP2480249A1 Use of plasmin for the treatment of filtration failure after trabeculectomy
08/01/2012EP2480247A2 Novel npr-b agonists
08/01/2012EP2480227A1 Retinal neuroprotection by ion channel blockers regulated by the sur subunit
08/01/2012CN1993333B Triazole derivative
08/01/2012CN102625808A Spirocyclic amide derivatives
08/01/2012CN102625804A Compounds useful for treating AIDS
08/01/2012CN102625709A Methods and compositions for preventing or treating ophthalmic conditions
08/01/2012CN102618535A Nucleotides, recombinant vector comprising nucleotides, cell, composition, and application of recombinant vector, cell and composition
08/01/2012CN102617784A Acrylic polymer material with high refractive index
08/01/2012CN102617557A Compositions and methods for treatment of eye disorders
08/01/2012CN102614443A Traditional Chinese drug preparation for treatments of eustachian tube blocking and otalgia under cold weather conditions
08/01/2012CN102614356A Chinese angelica, Chinese gentian and aloe membrane coat tablet and preparation method thereof
08/01/2012CN102614331A Chinese medicinal preparation for treating tinnitus and deafness
08/01/2012CN102614326A Preparation method of Tibetan drug for treating keratoconjunctivitis
08/01/2012CN102614264A Medicine for treating eyelid spasm
08/01/2012CN102614252A Prescription for treating cataract
08/01/2012CN102614211A Novel pharmaceutical usage of lincomycin
08/01/2012CN102614202A Mixture and liquid medicine or oral liquid for injection
07/2012
07/31/2012US8232383 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
07/31/2012US8232308 Methods for treating a disease in which Rho kinase is involved
07/31/2012US8232068 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
07/31/2012CA2506464C Therapeutic agent for glaucoma comprising rho kinase inhibitor and .beta.-blocker
07/31/2012CA2489965C Pharmaceutical compositions for the treatment of diseases related to neurotrophines
07/26/2012WO2012100109A2 Therapeutic eye drop comprising doxycycline and a stabilizer
07/26/2012WO2012099940A2 Methods and compositions for treating ocular disease
07/26/2012WO2012099448A2 RECOMBINANT ADENOVIRUS EXPRESSING αA-CRYSTALLIN GENE AND GENE THERAPY FOR RETINAL VASCULAR DISEASE USING SAME
07/26/2012WO2012099142A1 Bromfenac aqueous liquid composition having preservative efficiency
07/26/2012WO2012098143A1 Use of inhibitors of atp-sensitive potassium channels for the treatment of hearing loss
07/26/2012WO2012098000A1 Neramexane for the treatment or prevention of tinnitus related with stress or acute hearing loss
07/26/2012WO2012097640A1 Use of 3'4-dihydroxy-3, 5'-dimethoxybibenzil in the manufacture of medicaments for treating cataract
07/26/2012US20120190722 Ketorolac tromethamine compositions for treating or preventing ocular pain
07/26/2012US20120190705 Methods of inhibiting choroidal neovascularization
07/26/2012US20120190701 Renin inhibitors
07/26/2012US20120190695 Phenyloxadiazole derivatives as pgds inhibitors
07/26/2012US20120190694 Selective sphingosine-1-phosphate receptor antagonists
07/26/2012US20120190691 Pharmaceutical compositions for treatment of respiratory and inflammatory diseases
07/26/2012US20120190680 Heteroaryl Amide Analogues
07/26/2012US20120190671 Controlled-Release CNS Modulating Compositions and Methods for the Treatment of Otic Disorders
07/26/2012US20120190661 Androgen composition for treating an opthalmic condition
07/26/2012US20120190659 Angiogenesis inhibitors
07/26/2012US20120190654 Novel bicyclic urea compounds
07/26/2012US20120190653 Therapeutic eye drop comprising doxycycline and a stabilizer
07/26/2012US20120190650 Inhibitors of Autotaxin
07/26/2012US20120190629 Light-receiving channel rhodopsin having improved expression efficiency
07/26/2012US20120190621 Corneal endothelial cell proliferation promoter
07/26/2012US20120190616 Analogues of Insulin-Like Growth Factor-1 (IGF-1) Having Amino Acid Substitution at Position 59
07/26/2012US20120189646 Novel compounds
07/26/2012US20120189642 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
07/26/2012US20120189626 Treatment of complement-associated disorders
07/26/2012US20120189621 Combination Therapies and Methods Using Anti-CD3 Modulating Agents and Anti-IL-6 Antagonists
07/26/2012US20120189609 Improvement to trabeculectomy
07/26/2012US20120189583 Placental or umbilical cord tissue compositions
07/26/2012US20120189563 Oral composition for alleviating ultraviolet irradiation-induced damage
07/26/2012US20120189558 Anti-bacterial compositions comprising extracts of eremophila longifolia and methods for use of same
07/26/2012CA2824433A1 Aqueous liquid bromfenac composition having preservative efficacy
07/25/2012EP2478906A1 Latanoprost-containing aqueous eye drops and method for inhibiting adsorption of latanoprost to resin
07/25/2012EP2478361A2 Protein kinase conjugates and inhibitors
07/25/2012EP2478010A1 Partial peptide of lacritin
07/25/2012EP2292611B1 Novel thiophenediamine derivative having urea structure
07/25/2012EP1390349B1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
07/25/2012EP1322641B1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
07/25/2012CN102612524A Dual variable domain immunoglobulins and uses thereof
07/25/2012CN102604886A Method for generating autologous retinal stem cells and autologous retinal cells by reversely differentiating human body cells, kit and application of autologous retinal stem cells and autologous retinal cells
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 531